Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 795.00
+21.00 (2.71%)
Nov 13, 2026, 3:30 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 145.4 billion as of November 12, 2026. It is the 24,376th most valuable company in the world and the 987th biggest in South Korea. Its market cap has decreased by 60.93% in one year.
Market Cap
145.40B
Enterprise Value
n/a
Revenue
158.79B
Global Rank
Country Rank
#987 South Korea
PE Ratio
14.86
ChartMarket Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 145.40B, an increase of 135.26%. That is a compound annual growth rate of 2.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 145.40B | -60.25% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 167.82B |
| JW Lifescience | 165.07B |
| Samil Pharmaceutical Co.,Ltd | 157.72B |
| BNC KOREA | 155.60B |
| Dongwha Pharm.Co.,Ltd | 149.40B |
| Hana Pharm | 146.09B |
| Daihan Pharmaceutical | 145.82B |
| Ilsung Is | 145.30B |